AstraZeneca Pharma India Limited

NSE:ASTRAZEN.NS

7306.8 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Operating Activities:
Net Income 1,615.0861,341.046830.41,270.91,139.7726.7438332.04857.636-208.397-5.089-702.7292.5481,009.463883.9221,143.76953.489749.511647.761
Depreciation & Amortization 149.405162.6169.5197.5185.8149.2147.4158.26174.264152.815101.249122.78273.38688.12860.76768.76358.39957.30951.946
Deferred Income Tax 000-317.5-325-319.2-14000000000000
Stock Based Compensation 27.38123.71518.214.811.29.58.67.74.088142.89412.720000000
Change In Working Capital -1,281.658-301.984328.9-39.5-26.698.1-342.5-30.898420.949-325.781176.593612.334375.78151.577-233.939-21.977-170.88364.038-133.594
Accounts Receivables -506.231-236.3-47.1-45.7-58.6-281.3-116408-406.082123.264-170.07183.4060000000
Inventory -376.679-499.948195.853.5-470.3-49.6-554.4190.11994.01196.269-103.885-102.722-178.944-220.025-11.937-102.185102.257-88.9166.041
Accounts Payables -313.667374.496.7-313.4414.5552.776.9-449.300000000000
Other Working Capital -85.08159.86483.5266.187.8-123.7211.9-221.017326.938-422.049280.478715.056554.724271.602-222.00280.208-273.14152.954-139.635
Other Non Cash Items 1,612.112-642.396-339-78.4-110.9-114.5-149.6-76.322-82.964-75.642-280.829-92.776-364.451-504.158-385.035-374.065-443.942-324.654-285.236
Operating Cash Flow 599.558582.9811,0081,047.8874.2549.887.9383.089569.885-457.005-8.076-60.361377.264645.01325.714816.482397.063546.205280.876
Investing Activities:
Investments In Property Plant And Equipment -107.647-85.2-96.2-77.1-142.2-186.9-62.8-56.354-90.449-238.052-216.337-187.864-398.427-322.747-71.19-48.273-68.423-75.04-77.924
Acquisitions Net 4.13134.832.524.24.92.70.32.31.270000000000
Purchases Of Investments 000-1,714.2-1,690-330-110.8000000000000
Sales Maturities Of Investments 0001,690-4.9446.800.0900000000.0100.0561.88
Other Investing Activites 325231.46111.11,807.4124.2110.28058.79254.39151.61370.63731.68571.60745.88993.096100.941.4550.36834.419
Investing Cash Flow -103.516181.0647.41,730.3-1,70842.8-93.62.527-36.058-186.439-145.7-156.178-326.82-276.85821.90652.637-26.973-24.617-41.624
Financing Activities:
Debt Repayment -38.6-38.5-35.1-28.8-22.1000-2.7520-0.16100000000
Common Stock Issued 0000000000000000000
Common Stock Repurchased 0000000000000000000
Dividends Paid -400-200-50-50-30.1000000-89.096-249.604-249.318-373.884-371.483-297.666-99.019-247.33
Other Financing Activities -43.8-44.844-44.6-39.7-38.600-2.157-2.3950862.387-14.188-41.115-41.607-734.941-169.95-42.075-14.025-32.672
Financing Cash Flow -443.729-244.844-94.6-89.7-63.600-2.157-5.1460862.226-103.284-290.719-290.925-1,108.826-541.433-339.741-113.044-280.002
Other Information:
Effect Of Forex Changes On Cash 00.00800000000000000000
Net Change In Cash 53.623519.205960.82,688.4-897.4592.6-5.7383.459528.681-643.444708.45-319.823-240.27577.228-761.205327.68530.35408.544-40.75
Cash At End Of Period 5,058.4235,003.3744,484.23,523.48351,732.41,139.81,145.464762.006233.325876.77168.32488.143728.418676.8341,438.0391,110.3551,080.005671.461